FDA set to raise bar for clinical trials of CAR-T therapies
The FDA could make it harder for developers of CAR-T therapies to bring them to market by requiring full randomised controlled trials.
Lab-in-a-loop specialist Relation attracts Novartis alliance
UK-based AI and multi-omics company Relation Therapeutics will seek out targets for allergic diseases on behalf of Novartis in a $1.7bn-plus alliance.
FDA backs first AI tool for use in trials, targeting MASH
The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with MASH to help measure disease activity.
ASH: Jaypirca matches Imbruvica in first-line CLL trial
Eli Lilly has revealed the data it hopes will take BTK inhibitor Jaypirca into frontline use for chronic lymphocytic leukaemia.
ASH: FDA okays Gamida aplastic anaemia therapy as data drops
The first cell therapy for severe aplastic anaemia – Gamida Cell's Omisirge – has been approved by the FDA.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
5th mRNA-Based Therapeutics Summit Europe
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines
VuuAI and Amiculum partner to transform content engagement i...
Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a GenAI-driven content production automation plat
10th Tumor Models Summit San Francisco
Join the West Coast's premier pharma and biotech gathering, the 10th Tumor Models Summit San Francisco, where innovation meets opportunity
The PM Society Careers Event – 18th February 2026
Join us for our popular event to see how your skills and interests could add value to this vital and constantly evolving industry.
Frontiers Health Turns 10
Celebrating a Decade of Innovation and Collaboration in Berlin, November 11–12, 2025 Berlin / November 7th, 2025 | Marking its 10th anniversary,